Table 1. PBMC phenotype is affected after cryopreservation.
PBMC | Fresh (%) | Day 1 (%) | Day 28 (%) |
CD31+ | 67.38±2.17 | 70.42±4.12 | 76.88±2.10a,b |
CD31−CD34+ | 10.12±0.47 | 7.69±0.62a | 8.11±0.80a,b |
CD31−CD34+VEGFR2+ | 0.61±0.14 | 1.55±0.17 | 2.16±0.15 |
CD31−VEGFR2+ | 1.64±0.39 | 3.88±0.42a | 4.91±0.34a |
CD31+CD34−VEGFR2+ | 3.36±0.57 | 8.04±0.73a | 5.14±2.28a |
CD31+CD34−L-Selectin+VEGFR2+ | 3.50±0.24 | 5.12±1.10 | 6.31±0.70a |
CD31+CD34+ | 29.47±0.48 | 40.13±6.13 | 38.8±2.42 |
CD31+CD34+VEGFR2+ | 3.71±0.30 | 15.42±5.82 | 13.30±1.64 |
CD31+L-Selectin+ | 60.89±3.11 | 60.76±1.04 | 62.54±1.73 |
CD31+VEGFR2+ | 7.30±0.42 | 22.02±4.67 | 22.02±1.0 |
CD34+ | 35.89±1.36 | 48.14±2.72a | 43.93±2.59a |
CD34+L-Selectin− | 4.72±0.82 | 5.42±0.89 | 4.72±1.02 |
CD34+L-Selectin-VEGFR2+ | 0.61±0.22 | 3.66±0.61a | 2.58±0.76a |
CD34+L-Selectin+ | 27.44±1.58 | 24.91±0.61 | 23.39±1.92a |
CD34+L-Selectin+VEGFR2+ | 2.24±0.58 | 6.94±0.57a | 4.63±2.15 |
CD34+CD133+ | 0.14±0.053 | 0.53±.077a | 0.44±0.17 |
CD34+CD133+VEGFR2+ | 0.015±0.0082 | 0.15±0.043a | 0.12±0.049 |
CD34+VEGFR2+ | 2.33±0.56 | 11.66±2.99a | 7.63±2.81 |
L-Selectin+ | 84.37±1.52 | 74.79±2.43a | 70.76±2.82a |
L-Selectin−VEGFR2+ | 0.75±0.33 | 4.06±0.25a | 3.57±0.61a |
L-Selectin+VEGFR2+ | 3.66±0.56 | 6.40±0.79 | 5.08±1.61 |
CD133+ | 0.27±0.067 | 2.65±0.97a | 1.97±0.23a |
CD133+VEGFR2+ | 0.0027±0.0027 | 0.072±0.013a | 0.084±0.031a |
VEGFR2+ | 12.47±2.85 | 27.57±6.19a | 27.07±5.44a |
p<0.05 vs. ‘fresh’ time point.
p<0.05 vs. ‘day 1’ time point.
The values represent the percentage of cells within the total cell population (sample of 200,000 cells) that express the given phenotype.